Showing results (2031-2040 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|August 8, 2014
High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophagesLuigi Panico, Valentina Tenneriello, Fioravante Ronconi, et al.
Leukemia & Lymphoma|August 8, 2014
Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplantJuan Li, Beihui Huang, Ying Li, et al.
Leukemia & Lymphoma|August 8, 2014
Haploidentical hematopoietic stem cell transplant with umbilical cord-derived multipotent mesenchymal cell infusion for the treatment of high-risk acute leukemia in childrenLing Zhu, Zhidong Wang, Xiaoli Zheng, et al.
Leukemia & Lymphoma|August 12, 2014
Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphomaLiang Wang, Zhi-jun Wu-Xiao, Xiao-qin Chen, et al.
Leukemia & Lymphoma|July 17, 2014
Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblingsMauricette Michallet, Mohamad Sobh, Caroline Serrier, et al.
Leukemia & Lymphoma|July 18, 2014
Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemiaKirsten K Ness, Sue C Kaste, Liang Zhu, et al.
Leukemia & Lymphoma|July 25, 2014
Deacetylase inhibitors for the treatment of myelodysplastic syndromesElias Jabbour, Guillermo Garcia-Manero
Leukemia & Lymphoma|December 24, 2013
Future directions in the clinical management of amyloid light-chain amyloidosisSajjad Haider, Nisar Ahmad, Elias Anaissie, et al.
Leukemia & Lymphoma|December 24, 2013
Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndromeLijuan Han, Ling Li, Jingjing Wu, et al.
Leukemia & Lymphoma|December 24, 2013
Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacyAjay K Gopal, Nancy L Bartlett, Andres Forero-Torres, et al.
Pageof 1,001